Evoke Pharma, Inc. (EVOK)
- GlobeNewswire
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
SOLANA BEACH, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that management will participate in the Gastroenterology and Hepatology Advanced Practice Providers Conference taking place from September 12 – 14, 2024 at the Gaylord National Resort Convention Center in National Harbor, Maryland. “As a
- GlobeNewswire
Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that management will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place from September 9 – 11, 2024 at the Lotte New York Palace Hotel in New York City. Evoke’s presentation covering the recent positi
- Simply Wall St.
Evoke Pharma Second Quarter 2024 Earnings: Misses Expectations
Evoke Pharma ( NASDAQ:EVOK ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.55m (up 125% from 2Q...
